Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-035755

Chief Financial Officer sold 58,400 shares at an average $102.67 ($5,996,094)

  • Chief Financial Officer acquired 47,888 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bonstein Sara · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-21 Exercise or conversion : show line 1 in the form 10b5-1 +3,443 $26.46 $91,102 87,460 D
2025-07-21 Exercise or conversion : show line 2 in the form 10b5-1 +11,455 $28.88 $330,820 98,915 D
2025-07-21 Exercise or conversion : show line 3 in the form 10b5-1 +15,890 $29.13 $462,876 114,805 D
2025-07-21 Exercise or conversion : show line 4 in the form 10b5-1 +17,100 $34.03 $581,913 131,905 D
2025-07-21 Sale : show line 5 in the form 10b5-1 −32,090 $102.38 $3,285,374 99,815 D
2025-07-21 Sale : show line 6 in the form 10b5-1 −26,310 $103.03 $2,710,719 73,505 D
Open-market sales · 58,400 sh · avg $102.67 · $5,996,094

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-07-21 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −3,443 8,580 D
2025-07-21 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −11,455 0 D
2025-07-21 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −15,890 47,670 D
2025-07-21 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) −17,100 0 D
Loading xslF345X05/wk-form4_1753302879.xml…